Empower Clinics Inc. (CSE:EPW) (OTC PINK:EPWCF) has announced it intends to complete a direct spinout of a wholly owned subsidiary of the company and vend in a healthcare artificial intelligence technology or service company. The transaction is currently anticipated to proceed by way of plan of arrangement pursuant to which it is anticipated the subsidiary will be spun out to as a new issuer on the Canadian Securities Exchange, and in conjunction the target will be acquired. Empower shareholders will receive subsidiary company shares distributed directly to the shareholders of Empower on a pro-rata basis.

This is sponsored content issued on behalf of Empower Clinics Inc., please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this stock on the Empower Clinics Inc. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.


More From The Market Online
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.